Parvovirus B19 Antibodies Panel IgG IgM Test
Understanding Parvovirus B19 Infection
Parvovirus B19 is a common viral infection that primarily affects children, causing the characteristic “slapped cheek” rash of fifth disease. However, this virus can have serious implications for specific populations, including pregnant women, immunocompromised individuals, and those with blood disorders. The Parvovirus B19 Antibodies Panel IgG IgM Test provides comprehensive detection of both current and past infections, offering valuable insights for accurate diagnosis and appropriate medical management.
What Does This Test Measure?
This specialized panel detects two types of antibodies in your blood:
- IgM Antibodies: These indicate a recent or current infection, typically appearing within 7-10 days after exposure and persisting for 2-3 months
- IgG Antibodies: These demonstrate past infection and immunity, developing several weeks after initial infection and providing long-term protection
Clinical Significance of Antibody Detection
The combination of IgG and IgM results provides a complete picture of your parvovirus B19 status. A positive IgM with negative IgG suggests a recent infection, while positive IgG with negative IgM indicates past infection and immunity. When both antibodies are present, it may indicate a recent infection that is resolving.
Who Should Consider This Test?
This test is particularly important for individuals experiencing symptoms or belonging to high-risk groups:
Symptomatic Individuals
- Children or adults with characteristic “slapped cheek” rash
- Individuals experiencing joint pain and swelling, especially in women
- Patients with unexplained fever and flu-like symptoms
- Those with persistent anemia or blood abnormalities
High-Risk Populations
- Pregnant women exposed to parvovirus B19
- Immunocompromised patients (HIV, chemotherapy recipients, transplant patients)
- Individuals with hemoglobinopathies like sickle cell disease
- Healthcare workers with potential exposure
- Childcare providers and school staff
Benefits of Parvovirus B19 Testing
Choosing the Parvovirus B19 Antibodies Panel offers numerous advantages for your health management:
Accurate Diagnosis
Provides definitive confirmation of parvovirus B19 infection, distinguishing it from other viral illnesses with similar symptoms. This precision ensures appropriate treatment and prevents unnecessary antibiotic use.
Pregnancy Management
For pregnant women, early detection of parvovirus B19 infection is crucial. The virus can cross the placenta and cause fetal complications, including severe anemia and hydrops fetalis. Timely testing allows for proper monitoring and intervention when necessary.
Immune Status Assessment
Determines whether you have developed immunity from past infection, which is particularly valuable for healthcare workers and those in high-exposure occupations.
Comprehensive Health Insight
The panel approach provides a complete immunological profile, helping healthcare providers make informed decisions about treatment, isolation precautions, and follow-up care.
Understanding Your Test Results
Interpreting your Parvovirus B19 Antibodies Panel results requires professional medical guidance, but here’s a general overview of what your results might indicate:
Possible Result Patterns
- IgM Positive, IgG Negative: Indicates a recent or current infection. Medical follow-up and possible isolation may be recommended.
- IgM Negative, IgG Positive: Suggests past infection with developed immunity. No current infection concerns.
- Both IgM and IgG Positive: May indicate recent infection that is resolving. Further evaluation may be needed.
- Both IgM and IgG Negative: No evidence of current or past infection. Indicates susceptibility to parvovirus B19.
Clinical Implications
Your healthcare provider will consider your symptoms, medical history, and test results to determine the appropriate course of action. For pregnant women with positive IgM results, additional fetal monitoring through ultrasound may be recommended to detect potential complications.
Test Details and Pricing
| Test Component | Details |
|---|---|
| Test Name | Parvovirus B19 Antibodies Panel IgG IgM Test |
| Discount Price | $162 USD |
| Regular Price | $238 USD |
| Turnaround Time | Sample by Thursday 6 PM; Report Next Day |
| Sample Type | 2 mL (1 mL minimum) serum from 1 SST |
| Shipping Requirements | Refrigerated or frozen |
| Testing Method | Enzyme Immunoassay |
| Preparation | No special preparation required |
Nationwide Testing Availability
GGC DNA provides comprehensive Parvovirus B19 testing services across the United States. We have conveniently located branches in all major cities, ensuring accessible diagnostic services for patients nationwide. Our state-of-the-art facilities and experienced medical professionals guarantee accurate results and exceptional patient care.
Take Control of Your Health Today
Don’t let uncertainty about parvovirus B19 infection affect your health decisions. The Parvovirus B19 Antibodies Panel IgG IgM Test provides the clarity you need for proper diagnosis and management. With our discounted price of $162 USD and next-day results, you can quickly obtain the information necessary for informed healthcare decisions.
Ready to Schedule Your Test?
Contact GGC DNA today to book your Parvovirus B19 Antibodies Panel. Our friendly staff will assist you with scheduling and answer any questions you may have about the testing process.
Call or WhatsApp: +1(267) 388-9828
Take the first step toward accurate diagnosis and proper management of parvovirus B19 infection. Schedule your test with GGC DNA and benefit from our expertise in infectious disease testing and commitment to patient care.
